First Trust Advisors’s Nuvalent NUVL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.88M Buy
47,617
+25,452
+115% +$2.59M ﹤0.01% 1454
2025
Q4
$2.23M Buy
+22,165
New +$2.19M ﹤0.01% 1832
2025
Q3
Sell
-22,090
Closed -$1.69M 2693
2025
Q2
$1.69M Sell
22,090
-4,677
-17% -$342K ﹤0.01% 1892
2025
Q1
$1.9M Sell
26,767
-17,775
-40% -$1.39M ﹤0.01% 1803
2024
Q4
$3.49M Buy
44,542
+1,685
+4% +$157K ﹤0.01% 1562
2024
Q3
$4.38M Buy
42,857
+22,571
+111% +$1.87M ﹤0.01% 1399
2024
Q2
$1.54M Buy
20,286
+3,632
+22% +$258K ﹤0.01% 1814
2024
Q1
$1.25M Sell
16,654
-538
-3% -$42.8K ﹤0.01% 1919
2023
Q4
$1.27M Buy
+17,192
New +$1.06M ﹤0.01% 1910

Other funds holding NUVL

First Trust Advisors's NUVL Position: Q1 2026 in Review

First Trust Advisors increased its Nuvalent (NUVL) stake by 115% in Q1 2026, buying an estimated $2.59M and bringing the position to 47,617 shares worth $4.88M. The position accounts for ﹤0.01% of the portfolio, ranked #1454.

First Trust Advisors first reported a position in NUVL in Q4 2023 and has held it in 9 quarters since. 263 funds tracked by Wall St. Rank hold NUVL as of Q1 2026.

  • First Trust Advisors held 47,617 shares of Nuvalent worth $4.88M as of Q1 2026.
  • First Trust Advisors bought 25,452 Nuvalent shares in Q1 2026, an estimated $2.59M.
  • Nuvalent made up ﹤0.01% of First Trust Advisors's portfolio in Q1 2026, its #1454 holding.
  • First Trust Advisors first reported a position in Nuvalent in Q4 2023 and has held it in 9 quarters since.
  • 263 funds tracked by Wall St. Rank held Nuvalent as of Q1 2026.

Based on First Trust Advisors's 13F filing for Q1 2026, filed 13 May 2026.